We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
L-Type Calcium Channel Ca<sub>V</sub> 1.2 in Transgenic Mice Overexpressing Human AβPP751 with the London (V717I) and Swedish (K670M/N671L) Mutations.
- Authors
Willis, Michael; Kaufmann, Walter A.; Wietzorrek, Georg; Hutter-Paier, Birgit; Moosmang, Sven; Humpel, Christian; Hofmann, Franz; Windisch, Manfred; Knaus, Hans-Günther; Marksteiner, Josef
- Abstract
Cumulative evidence indicates that amyloid-β peptides exert some of their neurodegenerative effects through modulation of L-type voltage gated calcium channels, which play key roles in a diverse range of CNS functions. In this study we examined the expression of CaV1.2 L-type voltage gated calcium channels in transgenic mice overexpressing human AβPP751 with the London (V717I) and Swedish (K670M/N671L) mutations by immunohistochemistry in light and electron microscopy. In hippocampal layers of wild type and transgenic mice, CaV1.2 channels were predominantly localized to somato-dendritic domains of neurons, and to astrocytic profiles with an age-dependent increase in labeling density. In transgenic animals, CaV1.2-like immunoreactive clusters were found in neuronal profiles in association with amyloid-β plaques. Both the number and density of these clusters depended upon age of animals and number of plaques. The most striking difference between wild type and transgenic mice was the age-dependent expression of CaV1.2 channels in reactive astrocytes. At the age of 6 month, CaV1.2 channels were rarely detected in reactive astrocytes of transgenic mice, but an incremental number of CaV1.2 expressing reactive astrocytes was found with increasing age of animals and number of amyloid-β plaques. This study demonstrates that CaV1.2 channels are highly expressed in reactive astrocytes of 12-months of age transgenic mice, which might be a consequence of the increasing amyloid burden. Further studies should clarify which functional implications are associated with the higher availability of CaV1.2 channels in late stage Alzheimer's disease.
- Subjects
CALCIUM channels; TRANSGENIC mice; GENETIC mutation; ALZHEIMER'S disease; ASTROCYTES
- Publication
Journal of Alzheimer's Disease, 2010, Vol 20, Issue 4, p1167
- ISSN
1387-2877
- Publication type
Article
- DOI
10.3233/JAD-2010-091117